An object of the present invention is to study synthesis of a novel 1,2-dihydroquinoline derivative and to find a pharmacological action of the derivative. A compound represented by the general formula (1) or a salt thereof is effective in the treatment of a glucocorticoid receptor-related disease. In the formula, the ring X represents a benzene ring or a pyridine ring； R 1 represents a halogen atom, an alkyl group, a hydroxy group, an alkoxy group, an amino group or the like； p represents an integer of 0 to 5； R 2 represents a halogen atom, an alkyl group, a hydroxy group or the like； q represents an integer of 0 to 2； R 3 represents a hydrogen atom, an alkyl group, an alkenyl group or the like； R 4 and R 5 represent a hydrogen atom or the like； R 6 represents a hydrogen atom or the like； A represents an alkylene group or the like； and R 7 represents OR 8 , NR 8 R 9 , SR 8 , S (O) R 8 or S (O) 2 R 8 , wherein R 8 represents an aryl group, a heterocyclic group or the like and R 9 represents a hydrogen atom or the like.
